Saloni Wagh, Whole Time Director of Supriya Lifescience Ltd, and Satish Wagh, Chairman & MD, decode the company's IPO in this detailed review. The IPO opened on December 16, 2021, and closed on December 20, 2021, with a total size of ₹700 crore. This includes a fresh issue of ₹200 crore and an offer for sale of ₹500 crore. Supriya Lifescience, founded by Dr. Satish Wagh in 1987, is a leading supplier of pharmaceutical API ingredients, exporting to 87 countries. With 17.70% CAGR revenue growth over the past five years, the company plans to use the IPO proceeds for capital expenditure, capacity expansion, corporate expenses, and debt repayment.